SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001662252-16-000257
Filing Date
2016-11-21
Accepted
2016-11-21 10:46:10
Documents
52
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rcha10q.htm 10-Q 415615
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8543
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 8612
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 3736
  Complete submission text file 0001662252-16-000257.txt   3650010

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE rcha-20160930.xml EX-101.INS 627465
6 XBRL SCHEMA FILE rcha-20160930.xsd EX-101.SCH 65720
7 XBRL CALCULATION FILE rcha-20160930_cal.xml EX-101.CAL 31778
8 XBRL DEFINITION FILE rcha-20160930_def.xml EX-101.DEF 146030
9 XBRL LABEL FILE rcha-20160930_lab.xml EX-101.LAB 238506
10 XBRL PRESENTATION FILE rcha-20160930_pre.xml EX-101.PRE 224795
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54767 | Film No.: 162009399
SIC: 2834 Pharmaceutical Preparations